In our previous study, we observed a reduction in LAG3 expression in patients with SAA [2] and an increase in LAG3 expression in patients with MDS [3], suggesting that abnormal LAG3 expression may lead to the maladjustment of T-cell immunity, thus causing subsequent changes. Here, LAG3 is linked to myelodysplastic syndrome.